Benitec Biopharma Inc (BNTC)

R&D Expense Growth

52.66%

Quarterly · Period ending:

BNTC logo

BNTC R&D Expense Growth

Latest reported52.66%
BNTC Quarterly R&D Growth (QoQ) (0.00% → 52.66%)
High-resolution chart · PNG

BNTC r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Benitec Biopharma Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
52.6591%
7.9534%
73.1157%
-8.7957%
-43.1101%
20.6128%
50.2092%
2.0786%
36.8667%
-49.706%
15.1953%
39.0144%
0.5999%
-15.7937%
41.391%
-16.2469%
46.292%
-30.9917%
13.1655%
19.8276%
-15.8811%
136.1301%
50.9044%
-14.5695%
-31.6539%
55.8678%
35.3899%
-65.2267%
10.6416%
835.0029%
-78.8216%
-15.6475%
9.2861%
-20.719%
30.3326%
-11.4109%
9.8123%
28.6607%
-52.9587%
38.4152%
-45.8507%
59.5338%
-58.8288%
148.5239%
13.8715%
0.3203%
-4.7506%
15.3246%
0.1713%
15.3229%
-9.8053%
-57.3465%
-0.0768%
450.4497%
0.8903%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.